Venous Blood-Based Biomarkers in the China Health and Retirement Longitudinal Study: Rationale, Design, and Results From the 2015 Wave

被引：206

作者：

Chen, Xinxin ^{[1
]}

Crimmins, Eileen ^{[2
]}

Hu, Peifeng ^{[3
]}

Kim, Jung Ki ^{[2
]}

Meng, Qinqin ^{[1
]}

Strauss, John ^{[4
]}

Wang, Yafeng ^{[1
]}

Zeng, Junxia ^{[5
]}

Zhang, Yuan ^{[6
]}

Zhao, Yaohui ^{[7
]}

机构：

[1] Peking Univ, Inst Social Survey Res, Beijing, Peoples R China

[2] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90007 USA

[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[4] Univ Southern Calif, Dept Econ, Los Angeles, CA 90007 USA

[5] Chinese Acad Social Sci, Rural Dev Inst, Beijing, Peoples R China

[6] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27515 USA

[7] Peking Univ, Natl Sch Dev, 5 Yiheyuan Rd, Beijing 100871, Peoples R China

来源：

AMERICAN JOURNAL OF EPIDEMIOLOGY | 2019年 / 188卷 / 11期

关键词：

aging; biomarkers; CHARLS; study design; PREVALENCE; TRENDS;

D O I：

10.1093/aje/kwz170

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

100235 [预防医学];

摘要：

Blood biomarkers provide critical information about the health of older populations, especially in large developing countries where self-reports of health are often inaccurate due to lack of access to health care. However, it is very difficult to collect blood samples in representative population surveys in such countries. The China Health and Retirement Longitudinal Study (CHARLS), a nationally representative study of middle-aged and older Chinese, represents one of the first efforts to include blood biomarkers in a nationally representative survey of China. In the 2015 wave of CHARLS, 13,013 respondents located in 150 counties around China donated whole blood, which was assayed on a range of indicators. Here we describe the process of the sample collection, transportation, storage, and analysis and present basic statistics.

引用

页码：1871 / 1877

页数：7

共 12 条

[1]

Socioeconomic status and C-reactive protein levels in the US population: NHANES IV [J].